ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.
about
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewNon-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and managementUpdate on surgical treatment of pancreatic neuroendocrine neoplasmsPET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literatureCurrent knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumoursStreptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment StratificationGastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?Should surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systemic reviewPancreastatin predicts survival in neuroendocrine tumors.Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Therapy for metastatic pancreatic neuroendocrine tumors.Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent mannerPancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advancesGene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumorsPancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesionsTumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.Distal pancreatic resection for neuroendocrine tumors: is laparoscopic really better than open?A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review.Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report.Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms.Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine TumorsACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing Cushing's syndrome: a case reportPostoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor.Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.Extensive multiarterial resection attending total duodenopancreatectomy and adrenalectomy for MEN-1-associated neuroendocrine carcinomas.Pancreatic Aetiology for Massive Upper Gastrointestinal Haemorrhage in PregnancyENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
P2860
Q26768483-AB2F883F-05C1-44A4-8DB5-37F08B634303Q26795597-62518DE6-5F2D-4A4A-B291-966485073B56Q26864361-136157F2-7581-42C8-8EC4-828228E57672Q26992201-92C95979-E16F-46CB-AB3D-06E3103602A4Q28071483-E2A3CF00-9830-4359-8C44-9C61315FD299Q28551275-AF7EAFA7-C9B0-4504-ADDF-93E901F49C1DQ30249051-16B883A2-70C5-46A6-B91F-C4A973D5BA7AQ33573118-C5871779-5BE7-4558-ADB9-FABAEE23A37CQ33606047-85C62953-1105-4931-B256-1321B57DF83DQ33651984-3EFA3CE2-521F-4966-ADF5-282435CD44E5Q33737587-24BA4859-386B-4BE4-A048-A4E7559F1362Q33779718-2CFD4882-CE8F-4BA7-A05F-93F5BB2680BDQ33798859-AD85B8DD-B0A3-4963-A9EC-E4605A36BE05Q34016884-53054972-0585-4E9B-A04B-0037945B252EQ34130243-5998D0AF-E16B-4EE7-864C-2B3633269CF6Q34157385-2AB52DD8-33D5-4E4D-8181-9BCF690CAB27Q34357869-2CD870BD-78F8-4911-8104-48EB4AED3DFAQ34387994-761EC78C-8818-4AB4-A0B3-74488AE53558Q34446086-0827FB60-CB44-4411-BCDF-A7D55B2939E7Q34518263-A4D5DF4A-A1DB-465C-B690-8C828A567D4EQ34650411-D764C7FE-304F-41F7-BD70-D250889D0D3FQ34680094-0FB337AF-3317-48EF-A4B0-A2221363228CQ34702075-0E41C9C7-6FED-4E45-978A-0C0C421706ECQ35034000-89953807-9ABB-452C-8DD4-0A4E8D1643F6Q35547162-FAD8E90A-AE62-45EA-A867-ECE981848344Q35763588-7DEEC025-E657-424B-AFE5-551112597135Q35857794-084AF0AF-769C-40CD-A345-7377079906A9Q35891227-E1CD92D0-7A46-4A28-A890-113CB7DA0985Q36060458-D8CBEE42-9C2D-465D-ABCD-7EB89C63217FQ36065003-647D1EAF-58B6-44D1-BC68-D09A423CB3CDQ36126735-CBC6E3C4-6646-4B19-8B8F-447096BE545AQ36154116-679E24FF-ECEA-49D2-81EB-31F3F48EAE67Q36184629-48580B85-E723-4109-B489-F5620777F104Q36330126-78F0122D-CB5A-4C81-989A-C96563B5A774Q36465024-BA230E5C-ABB6-41AA-AD04-EDE01F41DD59Q36558826-01C9F565-15E1-4724-BABD-7AC72373BEBCQ36558853-8378898A-BC6C-4666-9DE8-E33D48EF5AA0Q36638258-461E1140-6707-42B3-A676-0554CB70131AQ36680840-15EBC7CE-1EDE-4C6F-8F0F-1D6BA9B0B7E2Q36849357-D2160974-9E46-4668-9398-B69DA2764D86
P2860
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@ast
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@en
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@nl
type
label
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@ast
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@en
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@nl
prefLabel
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@ast
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@en
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@nl
P2093
P2860
P50
P356
P1433
P1476
ENETS Consensus Guidelines for ...... reatic non-functioning tumors.
@en
P2093
Babs G Taal
Barbro Eriksson
Barcelona Consensus Conference participants
Dermot O'Toole
Detlef Klaus Bartsch
Juan M O'Connor
Marie Pierre Vullierme
Ramón Salazar
P2860
P304
P356
10.1159/000335587
P577
2012-02-15T00:00:00Z